252 related articles for article (PubMed ID: 18684027)
41. Endocrine precursor lesions of gastroenteropancreatic neuroendocrine tumors.
Klöppel G; Anlauf M; Perren A
Endocr Pathol; 2007; 18(3):150-5. PubMed ID: 18058264
[TBL] [Abstract][Full Text] [Related]
42. Pancreatic endocrine tumors.
Asa SL
Mod Pathol; 2011 Apr; 24 Suppl 2():S66-77. PubMed ID: 21455203
[TBL] [Abstract][Full Text] [Related]
43. New molecular aspects in the diagnosis and therapy of neuroendocrine tumors of the gastroenteropancreatic system.
Pape UF; Höcker M; Seuss U; Wiedenmann B
Recent Results Cancer Res; 2000; 153():45-60. PubMed ID: 10626288
[TBL] [Abstract][Full Text] [Related]
44. Digestive Neuroendocrine Tumor Distribution and Characteristics According to the 2010 WHO Classification: a Single Institution Experience in Lebanon.
Kourie HR; Ghorra C; Rassy M; Kesserouani C; Kattan J
Asian Pac J Cancer Prev; 2016; 17(5):2679-81. PubMed ID: 27268650
[TBL] [Abstract][Full Text] [Related]
45. Unraveling molecular pathways of poorly differentiated neuroendocrine carcinomas of the gastroenteropancreatic system: A systematic review.
Girardi DM; Silva ACB; Rêgo JFM; Coudry RA; Riechelmann RP
Cancer Treat Rev; 2017 May; 56():28-35. PubMed ID: 28456055
[TBL] [Abstract][Full Text] [Related]
46. [Clinical significance of new classification of gastroenteropancreatic neuroendocrine neoplasms].
Zhu XZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jan; 16(1):12-4. PubMed ID: 23691561
[TBL] [Abstract][Full Text] [Related]
47. Benefit of Gene Expression Profiling in Gastrointestinal Neuroendocrine Tumors of Unknown Primary Origin.
Saller JJ; Haider M; Al-Diffalha S; Coppola D
Anticancer Res; 2022 Mar; 42(3):1381-1396. PubMed ID: 35220231
[TBL] [Abstract][Full Text] [Related]
48. [Grading of neuroendocrine tumors].
Saeger W; Schnabel PA; Komminoth P
Pathologe; 2016 Jul; 37(4):304-13. PubMed ID: 27379621
[TBL] [Abstract][Full Text] [Related]
49. Revised classification of neuroendocrine tumors of the lung, pancreas and gut.
Capella C; Heitz PU; Höfler H; Solcia E; Klöppel G
Digestion; 1994; 55 Suppl 3():11-23. PubMed ID: 7698533
[TBL] [Abstract][Full Text] [Related]
50. Gastroenteropancreatic endocrine tumors.
Meeker A; Heaphy C
Mol Cell Endocrinol; 2014 Apr; 386(1-2):101-20. PubMed ID: 23906538
[TBL] [Abstract][Full Text] [Related]
51. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors.
Pape UF; Jann H; Müller-Nordhorn J; Bockelbrink A; Berndt U; Willich SN; Koch M; Röcken C; Rindi G; Wiedenmann B
Cancer; 2008 Jul; 113(2):256-65. PubMed ID: 18506737
[TBL] [Abstract][Full Text] [Related]
52. Expression of growth factors and their receptors in neuroendocrine gut and pancreatic tumors, and prognostic factors for survival.
Oberg K
Ann N Y Acad Sci; 1994 Sep; 733():46-55. PubMed ID: 7978895
[No Abstract] [Full Text] [Related]
53. Molecular genetics of gastroenteropancreatic neuroendocrine tumors.
Starker LF; Carling T
Curr Opin Oncol; 2009 Jan; 21(1):29-33. PubMed ID: 19125015
[TBL] [Abstract][Full Text] [Related]
54. Molecular genetic events in gastrointestinal and pancreatic neuroendocrine tumors.
Lubensky IA; Zhuang Z
Endocr Pathol; 2007; 18(3):156-62. PubMed ID: 18041590
[TBL] [Abstract][Full Text] [Related]
55. [Neuroendocrine tumors of the gastrointestinal tract].
Klöppel G
Pathologe; 2003 Jul; 24(4):287-96. PubMed ID: 14513276
[TBL] [Abstract][Full Text] [Related]
56. Defining molecular classifications and targets in gastroenteropancreatic neuroendocrine tumors through DNA microarray analysis.
Duerr EM; Mizukami Y; Ng A; Xavier RJ; Kikuchi H; Deshpande V; Warshaw AL; Glickman J; Kulke MH; Chung DC
Endocr Relat Cancer; 2008 Mar; 15(1):243-56. PubMed ID: 18310291
[TBL] [Abstract][Full Text] [Related]
57. Re-evaluation of cases with gastroenteropancreatic neuroendocrine tumors between 2004 and 2012 according to the 2010 criteria.
Ozkara S; Aker F; Yesil A; Senates E; Canbey C; Yitik A; Gonen C
Hepatogastroenterology; 2013 Oct; 60(127):1665-72. PubMed ID: 24627925
[TBL] [Abstract][Full Text] [Related]
58. Pancreatic neuroendocrine neoplasms: a current summary of diagnostic, prognostic, and differential diagnostic information.
Wick MR; Graeme-Cook FM
Am J Clin Pathol; 2001 Jun; 115 Suppl():S28-45. PubMed ID: 11993688
[TBL] [Abstract][Full Text] [Related]
59. The clinical implications and biologic relevance of neurofilament expression in gastroenteropancreatic neuroendocrine neoplasms.
Schimmack S; Lawrence B; Svejda B; Alaimo D; Schmitz-Winnenthal H; Fischer L; Büchler MW; Kidd M; Modlin I
Cancer; 2012 May; 118(10):2763-75. PubMed ID: 21990041
[TBL] [Abstract][Full Text] [Related]
60. What is New in the 2019 World Health Organization (WHO) Classification of Tumors of the Digestive System: Review of Selected Updates on Neuroendocrine Neoplasms, Appendiceal Tumors, and Molecular Testing.
Assarzadegan N; Montgomery E
Arch Pathol Lab Med; 2021 Jun; 145(6):664-677. PubMed ID: 32233993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
